Back to search
FDAFDA · Food and drugs·Recall number Z-3184-2024

BinaxNOW Respiratory Strep A Test Kit, CLIA Waived, Catalog Number 730025

Published September 25, 2024 · Recall initiated: August 20, 2024

Summary

FDA records medical device Class II recall Z-3184-2024, published September 25, 2024 and initiated August 20, 2024. Recalling firm: Cypress Medical Products LLC; Status: Ongoing; Reported quantity: 15 kits; Lot: GTIN: 10811877010453; All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to a classification error in our inventory management system, these medical devices were shipped to customers that did not have the requisite license to purchase such devices.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cypress Medical Products LLC
Distributor
US Nationwide distribution.
Lot
GTIN: 10811877010453; All Lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BinaxNOW Respiratory Strep A Test Kit, CLIA Waived, Catalog Number 730025 recalled?

Yes. FDA published recall Z-3184-2024 on September 25, 2024. Reported hazard: Due to a classification error in our inventory management system, these medical devices were shipped to customers that did not have the requisite license to purchase such devices.

What should I do if I have this product?

Voluntary: Firm initiated · Letter